Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
The New England Journal of Medicine
|
December 12, 2024
Four Years of Screening for Prostate Cancer with PSA and MRI. Reply
Jonas Hugosson, Rebecka Arnsrud Godtman, Johan Stranne
European Urology
|
May 24, 2016
Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767-8
Rebecka Arnsrud Godtman, Johan Stranne, Jonas Hugosson
European Urology
|
September 25, 2025
Reply to Kevin B. Ginsburg, Ava Zamani, and Tudor Borza's Letter to the Editor re: Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, Rebecka Arnsrud Godtman. Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial. Eur Urol. 2025;88:373-380
Emmeli Palmstedt, Jonas Hugosson, Rebecka Arnsrud Godtman
European Urology
|
May 1, 2026
The PROSA trial: Some Prosaic Comments
Rebecka Arnsrud Godtman, Jonas Wallström, Ola Bratt
European Urology
|
June 26, 2025
Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial
Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, et al.
European Urology
|
January 6, 2015
Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial
Rebecka Arnsrud Godtman, Erik Holmberg, Hans Lilja, et al.
The Journal of Urology
|
December 19, 2015
The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate Cancer
Rebecka Arnsrud Godtman, Sigrid Carlsson, Erik Holmberg, et al.
Lakartidningen
|
April 22, 2024
[Prostate cancer - diagnostics and screening]
Rebecka Arnsrud Godtman, Ola Bratt, Tobias Nordström, et al.
European Urology
|
September 18, 2012
Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial
Rebecka Arnsrud Godtman, Erik Holmberg, Ali Khatami, et al.
Scandinavian Journal of Urology
|
October 25, 2021
Constitutive expression of inducible nitric oxide synthase in healthy rat urothelium?
Rebecka Arnsrud Godtman, Lena Hallsberg, Zarah Löf-Öhlin, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
The New England Journal of Medicine
|
December 12, 2024
Four Years of Screening for Prostate Cancer with PSA and MRI. Reply
Jonas Hugosson, Rebecka Arnsrud Godtman, Johan Stranne
European Urology
|
May 24, 2016
Reply from Authors re: Roderick C.N. van den Bergh, Declan G. Murphy, Henk G. van der Poel. Expectant Management for Prostate Cancer: Lessons from the Past, Challenges for the Future. Eur Urol 2016;70:767-8
Rebecka Arnsrud Godtman, Johan Stranne, Jonas Hugosson
European Urology
|
September 25, 2025
Reply to Kevin B. Ginsburg, Ava Zamani, and Tudor Borza's Letter to the Editor re: Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, Rebecka Arnsrud Godtman. Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial. Eur Urol. 2025;88:373-380
Emmeli Palmstedt, Jonas Hugosson, Rebecka Arnsrud Godtman
European Urology
|
May 1, 2026
The PROSA trial: Some Prosaic Comments
Rebecka Arnsrud Godtman, Jonas Wallström, Ola Bratt
European Urology
|
June 26, 2025
Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial
Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, et al.
European Urology
|
January 6, 2015
Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial
Rebecka Arnsrud Godtman, Erik Holmberg, Hans Lilja, et al.
The Journal of Urology
|
December 19, 2015
The Effect of Start and Stop Age at Screening on the Risk of Being Diagnosed with Prostate Cancer
Rebecka Arnsrud Godtman, Sigrid Carlsson, Erik Holmberg, et al.
Lakartidningen
|
April 22, 2024
[Prostate cancer - diagnostics and screening]
Rebecka Arnsrud Godtman, Ola Bratt, Tobias Nordström, et al.
European Urology
|
September 18, 2012
Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial
Rebecka Arnsrud Godtman, Erik Holmberg, Ali Khatami, et al.
Scandinavian Journal of Urology
|
October 25, 2021
Constitutive expression of inducible nitric oxide synthase in healthy rat urothelium?
Rebecka Arnsrud Godtman, Lena Hallsberg, Zarah Löf-Öhlin, et al.
Page
of 6